Genistein modulates the effects of parathyroid hormone in human osteoblastic SaOS-2 cells

British Journal of Nutrition

Volumn 95, Issue 6, 2006, Pages 1039-1047

  Chen, Wen Fang ^a,b   Wong, Man Sau ^a,c  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^c State Key Laboratory of Chinese Medicine and Molecular Pharmacology   (China)

Author keywords

Alkaline phosphatase; Genistein; Osteoprotegrin; Parathyroid hormone; Receptor activator of nuclear factor B ligand

Indexed keywords

ALKALINE PHOSPHATASE; ANTIESTROGEN; ESTRADIOL; ESTROGEN; FULVESTRANT; GENISTEIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE;

ARTICLE; ATTENUATION; BONE DEVELOPMENT; CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; HORMONAL REGULATION; HUMAN; HUMAN CELL; MODULATION; OSTEOBLAST; PROTEIN EXPRESSION; UPREGULATION;

ALKALINE PHOSPHATASE; CARRIER PROTEINS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ESTRADIOL; ESTROGEN ANTAGONISTS; GENE EXPRESSION; GENISTEIN; GLYCOPROTEINS; HUMANS; IMMUNOBLOTTING; MEMBRANE GLYCOPROTEINS; OSTEOBLASTS; OSTEOPROTEGERIN; PARATHYROID HORMONE; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STIMULATION, CHEMICAL;

EID: 33745594281     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1079/BJN20061735     Document Type: Article

References (38)

1. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW & Toda T (2000) Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 72, 844-852.
2. Anderson JB, Chen XW & Garner SC (2000) Effects of genistein on MT3T3-E1, and osteoclast-like cell in relation to expression of estrogen receptors and during cell differentiation. J Nutr 130, 660S-667S.
3. Anderson JJ, Ambrose WW & Garner SC (1998) Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc Soc Exp Biol Med 217, 345-350.
4. Anonymous (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843, 11-23.
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
6. Bucay N, Sarosi I, Dunstan CR, et al. (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12, 1260-1268.
7. Chen X & Anderson JJB (2002) Effects of isoflavones on osteoblast proliferation and differentiation. J Nutr 132, 616S Abstr.
8. Chen X, Garner SC, Quarles LD & Anderson JJ (2003) Effects of genistein on expression of bone markers during MC3T3-E1 osteoblastic cell differentiation. J Nutr Biochem 14, 342-349.
9. Cusack S, Jewell C & Cashman KD (2001) The effect of estrogen and selected phytoestrogens on cell viability and molecular markers of SaOS-2 osteoblast-like activity. Ann Nutr Metab 45, 228 Abstr.
10. Deady J (2004) Clinical monograph: Hormone replacement therapy. J Manag Care Pharm 10, 33-47.
11. Dempster DW, Cosman F, Parisien M, Shen V & Lindsay R (1993) Anabolic actions of parathyroid hormone on bone. Endocr Rev 14, 690-709.
12. Denizot F & Lang R (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89, 271-277.
13. Goldwyn S, Lazinsky A & Wei H (2000) Promotion of health by soy isoflavones: Efficacy, benefit and safety concerns. Drug Metabol Drug Interact 17, 261-289.
14. Greendale GA, FitzGerald G, Huang MH, Sternfeld B, Gold E, Seeman T, Sherman S & Sowers M (2002) Dietary soy isoflavones and bone mineral density: Results from the study of women's health across the nation. Am J Epidemiol 155, 746-754.
15. Greenfield EM, Horowitz MC & Lavish SA (1996) Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts in an immediate-early gene response induced by cAMP signal transduction. J Biol Chem 271, 10984-10989.
16. Huang YF, Harrison JR, Lorenzo JA & Kream BE (1998) Parathyroid hormone induces interleukin-6 heterogenous nuclear and messenger RNA expression in murine calvarial organ cultures. Bone 23, 327-332.
17. Khosla S, Atkinson EJ, Melton LJ III & Riggs BL (1997) Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: A population-based study. J Clin Endocrinol Metab 82, 1522-1527.
18. King RA & Bursill DB (1998) Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am J Clin Nutr 67, 867-872.
19. Kong YY, Yoshida H, Sarosi I, et al. (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323.
20. Lacey DL, Timms E, Tan HL, et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176.
21. Lauderdale DS, Jacobsen SJ, Furner SE, Levy PS, Brody JA & Goldberg J (1997) Hip fracture incidence among elderly Asian-American populations. Am J Epidemiol 146, 502-509.
22. Masiukiewicz US, Mitnick M, Grey AB & Insogna KL (2000) Estrogen modulates parathyroid hormone-induced interleukin-6 production in vivo and in vitro. Endocrinology 141, 2526-2531.
23. Massion CG & Frankenfeld JK (1972) Alkaline phosphatase: Lability in fresh and frozen human serum and in lyophilized control material. Clin Chem 18, 366-373.
24. Mei J, Yeung SS & Kung AW (2001) High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86, 5217-5221.
25. Morabito N, Crisafulli A, Vergara C, et al. (2002) Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study. J Bone Miner Res 17, 1904-1912.
26. Murray E, Provvedini D, Curran D, Catherwood B, Sussman H & Manolagas S (1987) Characterization of a human osteoblastic osteosarcoma cell line (SAOS-2) with high bone alkaline phosphatase activity. J Bone Miner Res 2, 231-238.
27. Nasu M, Sugimoto T, Kaji H & Chihara K (2000) Estrogen modulates osteoblast proliferation and function regulated by parathyroid hormone in osteoblastic SaOS-2 cells: Role of insulin-like growth factor (IGF)-I and IGF-binding protein-5. J Endocrinol 167, 305-313.
28. Onyia JE, Libermann TA, Bidwell J, Arnold D, Tu Y, McClelland P & Hock JM (1997) Parathyroid hormone (1-34)-mediated interleukin-6 induction. J Cell Biochem 67, 265-274.
29. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF & Erdman JW Jr (1998) Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68, Suppl. 6, 1375S-1379S.
30. Rao LG, Wylie JN, Sutherland MS & Murray TM (1994) 17 Beta-estradiol and parathyroid hormone potentiate each other's stimulatory effects on alkaline phosphatase activity in SaOS-2 cells in a differentiation-dependent manner. Endocrinology 134, 614-620.
31. Ross PD, Norimatsu H, Davis JW, Yano K, Wasnich RD, Fujiwara S, Hosoda Y & Melton LJ III (1991) A comparison of hip fracture incidence among native Japanese. Japanese Americans, and American Caucasians. Am J Epidemiol 133, 801-809.
32. Santell RC, Kieu N & Helferich WG (2000) Genistein inhibits growth of estrogen-independent human breast cancer cells in culture but not in athymic mice. J Nutr 130, 1665-1669.
33. Slootweg MC, Ederveen AG, Schot LP, Schoonen WG & Kloosterboer HJ (1992) Oestrogen and progestogen synergistically stimulate human and rat osteoblast proliferation. J Endocrinol 133, R5-R8.
34. Valachovicova T, Slivova V & Sliva D (2004) Cellular and physiological effects of soy flavonoids. Mini Rev Med Chem 4, 881-887.
35. Viereck V, Grundker C, Blaschke S, Siggelkow H, Emons G & Hofbauer LC (2002) Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts. J Cell Biochem 84, 725-735.
36. Yamagishi T, Otsuka E & Hagiwara H (2001) Reciprocal control of expression of mRNAs for osteoclast differentiation factor and OPG in osteogenic stromal cells by genistein: Evidence for the involvement of topoisomerase II in osteoclastogenesis. Endocrinology 142, 3632-3637.
37. Yao GQ, Sun B, Hammond EE, Spencer EN, Horowitz MC, Insogna KL & Weir EC (1998) The cell-surface form of colony-stimulating factor-1 is regulated by osteotropic agents and supports formation of multinucleated osteoclast-like cells. J Biol Chem 237, 4119-4129.
38. Yasuda H, Shima. N, Nakagawa N, et al. (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 95, 3597-3602.